Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06921148 · ClinicalTrials.gov registry record · NA

Silk Bioprotein as a Wound Dressing for Double-Incision Mastectomy

A NA study of Wound Healing, sponsored by Indiana University.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT06921148 is a NA study of Wound Healing that is actively recruiting participants, run by Indiana University. The registered enrollment target is 50 participants, roughly in line with the 53-participant average among 11 other Wound Healing trials with a reported enrollment target. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06921148, a NA study of Wound Healing, is actively recruiting participants, sponsored by Indiana University.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

This study will investigate the utility of Silk bioprotein, an FDA-approved and readily available post-surgical dressing, as a wound dressing for patients undergoing double-incision mastectomy for female-to-male gender affirmation surgery.

Conditions Studied

Interventions

  • DEVICE Sylk Wound Dressing
  • DEVICE Dermabond/Prineo Dressing

Study Locations (1)

Indiana

  • Indiana University Health - Indianapolis

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2025-04-30
Est. Completion 2026-06-14
Phase NA

Sponsor

Indiana University

890 total trials

What the Registry Record Tells You About NCT06921148

The ClinicalTrials.gov registry entry for NCT06921148 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 53-participant average among 11 other Wound Healing trials with a reported enrollment target. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Wound Healing appearing as the primary indexed condition, and to 2 interventions - of which Sylk Wound Dressing is the first listed.

NCT06921148 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.

Frequently Asked Questions

What is clinical trial NCT06921148 about?

NCT06921148 is a clinical study titled "Silk Bioprotein as a Wound Dressing for Double-Incision Mastectomy". This study will investigate the utility of Silk bioprotein, an FDA-approved and readily available post-surgical dressing, as a wound dressing for patients undergoing double-incision mastectomy for female-to-male gender affirmation surgery.

What is the current status of trial NCT06921148?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-04-30. Estimated completion is 2026-06-14.

What conditions does trial NCT06921148 study?

This clinical trial studies the following conditions: Wound Healing.

What interventions are being tested in trial NCT06921148?

The interventions under investigation include: Sylk Wound Dressing (DEVICE), Dermabond/Prineo Dressing (DEVICE).

Who is sponsoring clinical trial NCT06921148?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06921148 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Wound Healing

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.